v3.24.1
Consolidated Statement of Operations - USD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Income Statement [Abstract]    
Revenue $ 498,917 $ 2,990,497
Cost of goods sold 5,133,996 6,043,506
Gross loss (4,635,079) (3,053,009)
Operating expenses:    
Research and development 7,418,026 6,845,451
Sales and marketing 1,721,191 1,874,658
General and administrative 14,382,132 11,503,788
Total operating expenses 23,521,349 20,223,897
Loss from operations (28,156,428) (23,276,906)
Other income (expense):    
Interest income 441,443 182,276
Change in fair value - warrant liability (3,350,320)
Change in fair value - derivative liability (4,253,000)
Unrealized gain (loss) on marketable securities 215,900 (1,713)
Realized gain on marketable securities 941,950 160,990
Total other income (expense), net (6,004,027) 341,553
Net loss prior to provision for income taxes (34,160,455) (22,935,353)
Provision for income taxes
Net loss (34,160,455) (22,935,353)
Preferred stock dividends (697,991)
Accretion of discounts to redemption value of H-7 convertible preferred stock (3,980,274)
Deemed dividend (Series H-5 warrants) (199,000)
Net loss attributable to common stockholders $ (39,037,720) $ (22,935,353)
Net loss per share, basic $ (8.19) $ (4.95)
Net loss per share, diluted $ (8.19) $ (4.95)
Weighted average common stock outstanding, basic 4,764,494 4,631,122
Weighted average common stock outstanding, diluted 4,764,494 4,631,122

Source